- Home
- ALLO vs BCAL Comparison
ALLO vs BCAL Comparison
Compare ALLO & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | BCAL |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 672.6M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALLO | BCAL |
|---|---|---|
| Price | $1.96 | $21.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | $8.35 | ★ $20.67 |
| AVG Volume (30 Days) | ★ 7.8M | 213.5K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | 34.09 | ★ 777.27 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | $6.67 |
| P/E Ratio | ★ N/A | $51.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $14.57 |
| 52 Week High | $4.46 | $22.00 |
Technical Indicators
Market Signals| Indicator | ALLO | BCAL |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 62.84 |
| Support Level | $1.56 | $17.97 |
| Resistance Level | $1.92 | $21.60 |
| Average True Range (ATR) | 0.12 | 0.54 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 40.82 | 70.12 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About BCAL Southern California Bancorp
California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.